YouTube - Sibutramine Safety and Obesity Treatment
Links shared publicly online about this topic.
- 900total visits
YouTube - Sibutramine Safety and Obesity Treatment
View full resource at youtube.com
Tags: Obesity, Weight Loss, Drug
Most Recently Shared on September 4, 2010 at 4:58 pm By:
RT @MedicalNewsNet: Safety of #Weight Loss Drug #Sibutramine Video w Dr. S Rössner by @mitchelzoler: http://youtu.be/MEodi6fgKTA
Also Shared By:
The Silent Treatment | Patient Advocacy - YouTube
youtube.com — “Research and regulatory bodies have long confirmed that poor communication in healthcare is harmful at best and deadly at worst. In the 2005 study, Silence K...” View full resource at youtube.com
Most Recently Shared on March 24, 2012 at 7:46 pm By:
Scott Reeves Health Communicator and Science Enthusiast
: Protocols and checklists don’t create a culture of safety. Need support from physicians, nurses and others: http://t.co/twO8ppNq
The Silent Treatment | Surgical Error - YouTube
youtube.com — “Research and regulatory bodies have long confirmed that poor communication in healthcare is harmful at best and deadly at worst. In the 2005 study, Silence K...” View full resource at youtube.com
Most Recently Shared on March 16, 2012 at 12:58 am By:
Patient safety checklists aren't effective when they're ignored, according to AACN's "Silent Treatment" study.... http://t.co/xBPUjA2a
The Silent Treatment | Patient Safety - YouTube
youtube.com — “Research and regulatory bodies have long confirmed that poor communication in healthcare is harmful at best and deadly at worst. In the 2005 study, Silence K...” View full resource at youtube.com
Most Recently Shared on March 11, 2012 at 3:36 pm By:
Our "Silent Treatment" study of 6500 nurses found poor workplace communication undercuts the effectiveness of... http://t.co/73dizMNp
A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Typ
onlinelibrary.wiley.com — “A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Type 2 Diabetes Mellitus Patients. - Borges - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on June 19, 2011 at 8:20 am By:
A Randomized, Parallel Group, Doubleâ€*blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (... http://bit.ly/kxWgY1
A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Typ
onlinelibrary.wiley.com — “A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Type 2 Diabetes Mellitus Patients. - Borges - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on June 19, 2011 at 8:19 am By:
A Randomized, Parallel Group, Doubleâ€*blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (... http://bit.ly/lDWJXI
A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Typ
onlinelibrary.wiley.com — “A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Type 2 Diabetes Mellitus Patients. - Borges - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on June 18, 2011 at 8:41 pm By:
Endocrinology Wisdom OW Health
A Randomized, Parallel Group, Doubleâ€*blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (... http://bit.ly/iAAVeh
Encouraging results from ReShape Duo Phase 1 study for treatment of obesity
news-medical.net — “ReShape Medical, Inc. today announces results of its U.S. Phase 1 investigational clinical study. This feasibility study of thirty subjects assessed the safety and effectiveness of the ReShape Duo in conjunction with lifestyle modification in patients with a body mass index of 30-40.” View full resource at news-medical.net
Most Recently Shared on June 17, 2011 at 12:24 pm By:
Obesity News: Encouraging results from ReShape Duo Phase 1 study for treatment of obesity: ReShape Medical, In... http://twurl.nl/16zbyp
YouTube - Teenage Obesity and Weight Loss Treatments
youtube.com — “Teenagers discuss the struggles with obesity, and treatment options available.” View full resource at youtube.com
Most Recently Shared on March 25, 2011 at 1:30 pm By:
Robert Halper Pharma and Health Social Media
@JoslinDiabetes Gastric Bypass Surgery http://youtu.be/zamRmNlrozg
Amylin, Takeda Halt Obesity Drug Study | Markets | Minyanville.com
minyanville.com — “There's yet another safety concern over an obesity treatment: Amylin and Takeda suspend human testing.” View full resource at minyanville.com
Most Recently Shared on March 16, 2011 at 4:46 pm By:
Amylin's Diet Drug Crumbles http://bit.ly/hOjLam
Manufacturers suspend study of investigational obesity drug combo
endocrinetoday.com — “A phase 2 study designed to explore the safety and efficacy of pramlintide/metreleptin, an investigational combination therapy for the treatment” View full resource at endocrinetoday.com
Most Recently Shared on March 16, 2011 at 3:40 pm By:
Manufacturers suspend study of investigational obesity drug combo http://bit.ly/fXq0oO
YouTube - drfredbloem's Channel
youtube.com — “This channel provides videos on cutting-edge holistic and integrative treatment modalities, including nutrition, detoxification, and treatment for obesity, diabetes, cardiovascular disease, and hormone imbalances.” View full resource at youtube.com
Most Recently Shared on March 12, 2011 at 4:24 am By:
Sound Medicine: August 15, 2010
soundmedicine.iu.edu — “Sound Medicine:August 15, 2010. Sound Medicine 08-15-10, Young Athletes & Hydration, High Birth-Weight & Obesity, Uninsured Have Higher Death Rates, Fewer County Health Officials, Physical Stimuli Can Prevent Strokes, Helping Babies Breathe, Safety of Anime Contact Lenses, . Listen to Sound Medicine, the weekly talk radio show sponsored by the IU School of Medicine and WFYI, 90.1 FM, the Indianapolis NPR affiliate.” View full resource at soundmedicine.iu.edu
Most Recently Shared on August 16, 2010 at 4:48 pm By:
STOP Sports Injuries Health Organization
Dr. Marj Albohm (@NATA1950 President) talks heat illness prevention and treatment with @SoundMedicine http://bit.ly/9ogBV1 #sports #safety
US health experts advise against new obesity drug - Yahoo! News UK
uk.news.yahoo.com — “A panel of experts advising the US Food and Drug Administration voted Thursday against approving for sale a new obesity treatment called Qnexa, citing safety risks.” View full resource at uk.news.yahoo.com
Most Recently Shared on July 16, 2010 at 12:04 am By:
US health experts advise against new obesity drug: A panel of experts advising the US Food and Drug Administratio... http://yhoo.it/dmUfcb
Surgery Medical News about Obesity
mdlinx.com — “Short-term safety and efficacy of the Trans-oral Endoscopic Restrictive Implant System for the treatment of obesity” View full resource at mdlinx.com
Most Recently Shared on June 15, 2010 at 4:07 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Short-term safety and efficacy of the Trans-oral Endoscopic Restrictive Implant System for the treatment of o... http://bit.ly/ahi2s1 #SURG
Positive results from VIVUS' Phase 3 study of avanafil for ED in men with diabetes
news-medical.net — “VIVUS, Inc. today announced positive results from the phase 3 REVIVE-Diabetes (TA-302) study, evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED) in men with type 1 and type 2 diabetes. The REVIVE-Diabetes study met all three primary endpoints across the two doses studied by demonstrating statistically significant improvement in erectile function as measured by the Sexual Encounter Profile (SEP) and improvements in the Internatio” View full resource at news-medical.net
Most Recently Shared on June 7, 2010 at 12:27 pm By:
Positive results from VIVUS' Phase 3 study of avanafil for ED in men with diabetes: VIVUS, Inc. today announced po... http://bit.ly/bMSIZ6
Advertisement
Bob Finn - Medical News Net
@MedicalNewsNet
Safety of #Weight Loss Drug #Sibutramine in #Obesity. Video w Dr. Stephan Rössner by @mitchelzoler for MNN http://youtu.be/MEodi6fgKTA
1 year ago...